These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

2241 related items for PubMed ID: 22244725

  • 1. [Renal disorders associated with monoclonal gammopathies: diagnostic and therapeutic progress].
    Bridoux F, Delbes S, Sirac C, Pourreau F, Puyade M, Desport E, Jaccard A, Fermand JP, Touchard G.
    Presse Med; 2012 Mar; 41(3 Pt 1):276-89. PubMed ID: 22244725
    [Abstract] [Full Text] [Related]

  • 2. [Classification and therapeutic management of monoclonal gammopathies of renal significance].
    Javaugue V, Bouteau I, Sirac C, Quellard N, Diolez J, Colombo A, Desport E, Ecotière L, Goujon JM, Fermand JP, Touchard G, Jaccard A, Bridoux F.
    Rev Med Interne; 2018 Mar; 39(3):161-170. PubMed ID: 28457684
    [Abstract] [Full Text] [Related]

  • 3. [Current treatment of AL amyloidosis].
    Desport E, Moumas E, Abraham J, Delbès S, Lacotte-Thierry L, Touchard G, Fermand JP, Bridoux F, Jaccard A.
    Nephrol Ther; 2011 Nov; 7(6):467-73. PubMed ID: 21497573
    [Abstract] [Full Text] [Related]

  • 4. Immunoglobulin light chain amyloidosis: 2014 update on diagnosis, prognosis, and treatment.
    Gertz MA.
    Am J Hematol; 2014 Dec; 89(12):1132-40. PubMed ID: 25407896
    [Abstract] [Full Text] [Related]

  • 5. The Complexity and Heterogeneity of Monoclonal Immunoglobulin-Associated Renal Diseases.
    Sethi S, Rajkumar SV, D'Agati VD.
    J Am Soc Nephrol; 2018 Jul; 29(7):1810-1823. PubMed ID: 29703839
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [Diagnosis and treatment of kidney involvement in plasma cell diseases : Renal involvement in multiple myeloma and monoclonal gammopathies].
    Gödecke V, Schmidt JJ, Bräsen JH, Koenecke C, Haller H.
    Internist (Berl); 2019 Jan; 60(1):10-22. PubMed ID: 30635666
    [Abstract] [Full Text] [Related]

  • 8. Disappearance of immunoglobulins from persistent renal amyloid deposits following stem cell transplantation for heavy-and light-chain amyloidosis.
    Safadi S, Saad A, Quint PS, Sethi S, Leung N, Kurtin P, Nasr SH.
    Nephrol Dial Transplant; 2015 Jul; 30(7):1151-5. PubMed ID: 25796445
    [Abstract] [Full Text] [Related]

  • 9. The ultrastructural basis of renal pathology in monoclonal gammopathies.
    Santostefano M, Zanchelli F, Zaccaria A, Poletti G, Fusaroli M.
    J Nephrol; 2005 Jul; 18(6):659-75. PubMed ID: 16358223
    [Abstract] [Full Text] [Related]

  • 10. Kidney diseases associated with monoclonal immunoglobulin M-secreting B-cell lymphoproliferative disorders: a case series of 35 patients.
    Chauvet S, Bridoux F, Ecotière L, Javaugue V, Sirac C, Arnulf B, Thierry A, Quellard N, Milin S, Bender S, Goujon JM, Jaccard A, Fermand JP, Touchard G.
    Am J Kidney Dis; 2015 Nov; 66(5):756-67. PubMed ID: 25987261
    [Abstract] [Full Text] [Related]

  • 11. Renal monoclonal immunoglobulin deposition disease: a report of 64 patients from a single institution.
    Nasr SH, Valeri AM, Cornell LD, Fidler ME, Sethi S, D'Agati VD, Leung N.
    Clin J Am Soc Nephrol; 2012 Feb; 7(2):231-9. PubMed ID: 22156754
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Rapid Deterioration of the Renal Function Caused by the Coexistence of Intratubular Amyloidosis and Myeloma Cast Nephropathy.
    Kato H, Fujigaki Y, Asakawa S, Yamaguchi Y, Uozaki H, Komatsuda A, Nagata M, Uchida S.
    Intern Med; 2015 Feb; 54(23):3023-8. PubMed ID: 26631886
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Kidney and liver involvement in monoclonal light chain disorders.
    Pozzi C, Locatelli F.
    Semin Nephrol; 2002 Jul; 22(4):319-30. PubMed ID: 12118397
    [Abstract] [Full Text] [Related]

  • 16. Lenalidomide and dexamethasone for systemic AL amyloidosis following prior treatment with thalidomide or bortezomib regimens.
    Mahmood S, Venner CP, Sachchithanantham S, Lane T, Rannigan L, Foard D, Pinney JH, Gibbs SD, Whelan CJ, Lachmann HJ, Gillmore JD, Hawkins PN, Wechalekar AD.
    Br J Haematol; 2014 Sep; 166(6):842-8. PubMed ID: 24930361
    [Abstract] [Full Text] [Related]

  • 17. Al amyloidosis.
    Desport E, Bridoux F, Sirac C, Delbes S, Bender S, Fernandez B, Quellard N, Lacombe C, Goujon JM, Lavergne D, Abraham J, Touchard G, Fermand JP, Jaccard A, Centre national de référence pour l’amylose AL et les autres maladies par dépôts d’immunoglobulines monoclonales.
    Orphanet J Rare Dis; 2012 Aug 21; 7():54. PubMed ID: 22909024
    [Abstract] [Full Text] [Related]

  • 18. Paraprotein-Related Kidney Disease: Kidney Injury from Paraproteins-What Determines the Site of Injury?
    Doshi M, Lahoti A, Danesh FR, Batuman V, Sanders PW, American Society of Nephrology Onco-Nephrology Forum.
    Clin J Am Soc Nephrol; 2016 Dec 07; 11(12):2288-2294. PubMed ID: 27526707
    [Abstract] [Full Text] [Related]

  • 19. Unravelling the immunopathological mechanisms of heavy chain deposition disease with implications for clinical management.
    Bridoux F, Javaugue V, Bender S, Leroy F, Aucouturier P, Debiais-Delpech C, Goujon JM, Quellard N, Bonaud A, Clavel M, Trouillas P, Di Meo F, Gombert JM, Fermand JP, Jaccard A, Cogné M, Touchard G, Sirac C.
    Kidney Int; 2017 Feb 07; 91(2):423-434. PubMed ID: 27773425
    [Abstract] [Full Text] [Related]

  • 20. [Complete remission of nephrotic syndrome and improvement of renal function in a patient with light chain deposition disease following high dose chemotherapy with transplantation of autologous haematopoietic stem cells. A case study and review of literature].
    Adam Z, Krejcí M, Pour L, Stepánková S, Cermáková Z, Voska L, Teplan V, Krivanová A, Hájek R, Mayer J.
    Vnitr Lek; 2009 Nov 07; 55(11):1089-96. PubMed ID: 20017442
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 113.